Letter to the Editor: Cancer Research Must Continue Even Amid Pandemic
As the country continues to deal with the coronavirus pandemic, itís important lawmakers and the public remember that research into other diseases must also continue. Thatís why I recently took part in a virtual event where I met with Devin Kelsey, staff member for Congressman Cleaver, Nick Seelinger, staff member for Senator Blunt, and Daniel Kishi, staff member for Senator Hawley, as a volunteer for the American Cancer Society Cancer Action Network (ACS CAN).
During this meeting I made it clear that the people of Missouri are counting on our lawmakers to increase funding for cancer research and prevention. That with more than 600,000 Americans expected to die from cancer this year, including 13,010 in Missouri, now is not the time to take a break. We are at a point where advancements in research are saving more lives than ever, and itís critical that we keep this momentum going forward. Now is not the time to turn back the clock on progress made. Now is the time to invest in lifesaving cancer research.
By increasing medical research funding at the National Institutes of Health by $3 billion, we can continue to make progress in the fight against cancer.
Director of a nonprofit and volunteer for ACS CAN